Then, IHC was performed on neuroblastoma, SCLC, and NSCLC tumour xenografts and demonstrated enhanced expression of ACAA2 in neuroblastoma and SCLC relative to NSCLC (Fig. 4c). This evidence concerns the gene ACAA2 and non-small cell lung carcinoma.